Document is current
Any future updates will be listed below
-
Authors
Guermazi, Ali https://orcid.org/0000-0002-9374-8266
Eckstein, Felix
Gold, Garry
Hayashi, Daichi
Jarraya, Mohamed
Kogan, Feliks
Li, Xiaojuan
Link, Thomas M.
Nebelung, Sven
Oei, Edwin H. G.
Omoumi, Patrick
Saarakkala, Simo
Trattnig, Siegfried
Wirth, Wolfgang https://orcid.org/0000-0002-2297-8283
Roemer, Frank W. https://orcid.org/0000-0001-9238-7350
- License Information
-
More Information
Article History
Accepted: 9 January 2026
First Online: 3 February 2026
Competing interests
: A.G. is the president and co-owner of Boston Core Imaging Lab (BICL), LLC., a company that provides image assessment devices to academia and the pharmaceutical industry; has received consulting fees from TissueGene, Novartis, ICM, Paradigm, Formation Bio, 4Moving, Scarcell Therapeutics, Pacira, Coval, Medipost, Levicept and Peptinov; is the co-editor-in-chief of Skeletal Radiology . F.E. is the co-owner and CEO of Chondrometrics GmbH, a company that provides MR image analysis services to academic researchers and to the pharmaceutical industry; has provided consulting services to MerckSerono, Galapagos/Servier, Kolon Tissue Gene, Novartis, Peptinov, Formation Bio, 4 P Pharma, Sanofi and Artialis. D.H. has received publication royalties from Wolters Kluwer. S.N. has received lecture honoraria by Bayer Vital AG. E.H.G.O. has received research support from GE Healthcare. W.W. is in part-time employment with Chondrometrics GmbH and is a co-owner of Chondrometrics GmbH. F.W.R. is the CMO, director of research and shareholder of Boston Imaging Core Lab (BICL), LLC. F.W.R. is editor-in-chief of Osteoarthritis Imaging . G.G., M.J., F.K., X.L., T.M.L., P.O., S.S. and S.T. declare no competing interests.
